Abstract
Non-small-cell lung cancer (NSCLC) is an increasing global challenge, especially in low-income countries. Most guidelines for the management of advanced-stage NSCLC have limited effect in countries with resource constraints. Following a systematic literature search, we present an overview of the management of advanced-stage NSCLC in the first-line setting, discuss resources required for systemic therapy, and provide treatment recommendations stratified to four resources levels. Treatment guidelines appropriate for different resource levels offer a realistic approach to management of advanced-stage NSCLC, by recognising the limitations of a particular health-care system. Although there are many barriers to cancer control in low-resource countries, these can be overcome by using measures that are culturally appropriate, economically feasible, and evidence-based. Initiatives include strategic planning, tobacco control, training of health-care workers, access to therapeutic agents, acquisition of information, public education, and alliances with established institutions and international organisations.
| Original language | English |
|---|---|
| Pages (from-to) | 1102-1110 |
| Number of pages | 9 |
| Journal | The Lancet Oncology |
| Volume | 10 |
| Issue number | 11 |
| DOIs | |
| Publication status | Published - 2009 Nov |
Fingerprint
All Science Journal Classification (ASJC) codes
- Oncology
Cite this
}
First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia : consensus statement from the Asian Oncology Summit 2009. / Soo, Ross A.; Anderson, Benjamin O.; Cho, Byoung Chul; Yang, Chih Hsin; Liao, Meilin; Lim, Wan Teck; Goldstraw, Peter; Mok, Tony S.
In: The Lancet Oncology, Vol. 10, No. 11, 11.2009, p. 1102-1110.Research output: Contribution to journal › Review article
TY - JOUR
T1 - First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia
T2 - consensus statement from the Asian Oncology Summit 2009
AU - Soo, Ross A.
AU - Anderson, Benjamin O.
AU - Cho, Byoung Chul
AU - Yang, Chih Hsin
AU - Liao, Meilin
AU - Lim, Wan Teck
AU - Goldstraw, Peter
AU - Mok, Tony S.
PY - 2009/11
Y1 - 2009/11
N2 - Non-small-cell lung cancer (NSCLC) is an increasing global challenge, especially in low-income countries. Most guidelines for the management of advanced-stage NSCLC have limited effect in countries with resource constraints. Following a systematic literature search, we present an overview of the management of advanced-stage NSCLC in the first-line setting, discuss resources required for systemic therapy, and provide treatment recommendations stratified to four resources levels. Treatment guidelines appropriate for different resource levels offer a realistic approach to management of advanced-stage NSCLC, by recognising the limitations of a particular health-care system. Although there are many barriers to cancer control in low-resource countries, these can be overcome by using measures that are culturally appropriate, economically feasible, and evidence-based. Initiatives include strategic planning, tobacco control, training of health-care workers, access to therapeutic agents, acquisition of information, public education, and alliances with established institutions and international organisations.
AB - Non-small-cell lung cancer (NSCLC) is an increasing global challenge, especially in low-income countries. Most guidelines for the management of advanced-stage NSCLC have limited effect in countries with resource constraints. Following a systematic literature search, we present an overview of the management of advanced-stage NSCLC in the first-line setting, discuss resources required for systemic therapy, and provide treatment recommendations stratified to four resources levels. Treatment guidelines appropriate for different resource levels offer a realistic approach to management of advanced-stage NSCLC, by recognising the limitations of a particular health-care system. Although there are many barriers to cancer control in low-resource countries, these can be overcome by using measures that are culturally appropriate, economically feasible, and evidence-based. Initiatives include strategic planning, tobacco control, training of health-care workers, access to therapeutic agents, acquisition of information, public education, and alliances with established institutions and international organisations.
UR - http://www.scopus.com/inward/record.url?scp=71549117595&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=71549117595&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(09)70238-4
DO - 10.1016/S1470-2045(09)70238-4
M3 - Review article
C2 - 19880064
AN - SCOPUS:71549117595
VL - 10
SP - 1102
EP - 1110
JO - The Lancet Oncology
JF - The Lancet Oncology
SN - 1470-2045
IS - 11
ER -